CompletedPhase 1NCT02564354

Exploratory Study to Evaluate QR-010 in Subjects With Cystic Fibrosis ΔF508 CFTR Mutation

Studying Cystic fibrosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
ProQR Therapeutics
Principal Investigator
John P Clancy, MD
Cincinnati Childrens Hospital Medical Center
Intervention
QR-010(drug)
Enrollment
18 enrolled
Eligibility
18 years · All sexes
Timeline
20152016

Study locations (5)

Collaborators

European Commission

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02564354 on ClinicalTrials.gov

Other trials for Cystic fibrosis

Additional recruiting or active studies for the same condition.

See all trials for Cystic fibrosis

← Back to all trials